Search

everythinglearnresearchcommunity

for

Search:↓

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Early treatment helps stop hair loss in women of color.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Early diagnosis and biotin treatment are crucial for infants with biotinidase deficiency to prevent severe complications.

Biotin treatment improves symptoms of biotinidase deficiency, but some neurological damage may be permanent.

The document's conclusion cannot be provided as the content is not available for parsing.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Hair loss in rural Indian children is often due to malnutrition, poor grooming, stress, and infections.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Platelet-Rich Plasma may improve skin health and reduce wrinkles, but more research is needed for standard treatment guidelines.

COVID-19 can cause different skin issues, including rashes and hair loss.

PCOS has many symptoms, with high androgen levels being the most common.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.